betaine has been researched along with Glioblastoma in 1 studies
glycine betaine : The amino acid betaine derived from glycine.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morimoto, N | 1 |
| Yamamoto, M | 1 |
1 other study available for betaine and Glioblastoma
| Article | Year |
|---|---|
Effective Permeation of Anticancer Drugs into Glioblastoma Spheroids via Conjugation with a Sulfobetaine Copolymer.
Topics: Animals; Antineoplastic Agents; Betaine; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carrie | 2020 |